Incyte Corporation
ANTI-CD73 ANTIBODIES AND USES THEREOF

Last updated:

Abstract:

Anti-CD73 antibodies are disclosed. Also disclosed are related nucleic acids, vectors, cells, and pharmaceutical compositions. Methods of treating cancer with the anti-CD73 antibodies are also disclosed.

Status:
Application
Type:

Utility

Filling date:

30 Dec 2020

Issue date:

29 Jul 2021